II
CSII

Ibex Investors’s Cardiovascular Systems, Inc. CSII Stock Holding History

Ibex Investors’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,592
Closed -$219K – 265
2018
Q3 		$219K Buy
+5,592
New +$207K 0.12% 63

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Ibex Investors's CSII Position: Q4 2018 in Review

Ibex Investors sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2018, closing a stake of 5,592 shares — an estimated $219K sold.

Ibex Investors first reported a position in CSII in Q3 2018 and held it in 1 quarter. The position peaked at $219K in Q3 2018. 148 funds tracked by Wall St. Rank hold CSII as of Q4 2018.

  • Ibex Investors reported no remaining Cardiovascular Systems, Inc. position as of Q4 2018 after selling out during the quarter.
  • Ibex Investors sold 5,592 Cardiovascular Systems, Inc. shares in Q4 2018, an estimated $219K.
  • Ibex Investors first reported a position in Cardiovascular Systems, Inc. in Q3 2018 and held it in 1 quarter.
  • Ibex Investors's Cardiovascular Systems, Inc. position peaked at $219K in Q3 2018.
  • 148 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2018.

Based on Ibex Investors's 13F filing for Q4 2018, filed 13 Feb 2019.